Post- Rotatory Nystagmus Test: Normative Data for Spanish Adolescents and Adults

NCT04788134 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 163

Last updated 2021-03-09

No results posted yet for this study

Summary

The vestibulo-ocular reflex is the motor response of our eyes in the opposite direction to a translational or rotational movement of our head. The post-rotational nystagmus test (PRN) assesses the integrity of this reflex, thus assessing the perception of the vestibular system. The duration of this reflex after administering this test has been widely studied in children from 2 months to 12 years and 11 months of age. However, there is a knowledge gap from that age that the present study seeks to address.

Conditions

  • Vestibular Function Tests
  • Nystagmus Vestibular

Interventions

DIAGNOSTIC_TEST

Post-rotatory nystagmus test

The test is administrated with the person sit down with cross legs at a rotatory board, with the head positioned by the examiner in 30° of forward flexion. The position was maintained by the administration of the test. The administration consist in two administrations separate by one minute. Each administration consist in rotate the person 10 times in 20 seconds (the first 10 rotations in a counterclockwise direction in 20 s and the second 10 rotations in a clockwise direction in 20 s). After each administration the examiner counts the duration of the reflex in seconds.

Sponsors & Collaborators

  • Quesada, Rocío Vico

    lead INDIV

Principal Investigators

  • Vico Rocío · Quesada, Rocío Vico

  • Pedrero Yolanda · Quesada, Rocío Vico

  • Zisa Nerina · Quesada, Rocío Vico

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2021-06-01
Completion
2021-09-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04788134 on ClinicalTrials.gov